Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pharming Group N.V (PHAR) Short-term Investments: 2019-2024

Historic Short-term Investments for Pharming Group N.V (PHAR) over the last 6 years, with Dec 2024 value amounting to $1.5 million.

  • Pharming Group N.V's Short-term Investments rose 30.17% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year increase of 30.17%. This contributed to the annual value of $1.5 million for FY2024, which is 1.51% down from last year.
  • Pharming Group N.V's Short-term Investments amounted to $1.5 million in FY2024, which was down 1.51% from $1.5 million recorded in FY2023.
  • Pharming Group N.V's 5-year Short-term Investments high stood at $1.5 million for FY2023, and its period low was $812,000 during FY2021.
  • Its 3-year average for Short-term Investments is $1.4 million, with a median of $1.5 million in 2024.
  • In the last 5 years, Pharming Group N.V's Short-term Investments slumped by 60.87% in 2020 and then soared by 39.04% in 2023.
  • Over the past 5 years, Pharming Group N.V's Short-term Investments (Yearly) stood at $995,000 in 2020, then dropped by 18.39% to $812,000 in 2021, then soared by 35.34% to $1.1 million in 2022, then spiked by 39.04% to $1.5 million in 2023, then decreased by 1.51% to $1.5 million in 2024.